Author:
Thapa Raba,Sharma Sanjita,Pradhan Eli,Duwal Sushma,Poudel Manish,Shrestha Krishna Gopal,Paudyal Govinda Prasad
Abstract
Abstract
Background
This study aimed to assess the prevalence and associated factors of diabetic retinopathy (DR) and vision threatening DR (VTDR) among people with diabetes screened using fundus photography in Nepal.
Methods
This is a retrospective study among people with diabetes presented for DR screening using fundus photography from 2013 to 2019. Detailed demographics, duration of diabetes, medical history, visual acuity, and grading of DR on fundus photography were analyzed. Fundus camera used in the study were;Topcon digital fundus camera 900 CXR and digital portable fundus cameras (Nidek-10 portable non-mydriatric fundus camera; Versacam & Trade & Alpha, France), and a Zeiss portable fundus camera (Zeiss Visucout 100). Macula centred and disc centred 45 degree two images were taken from each eye. Pupil were dilated in cases where there was media haze in un-dilated cases. DR was graded using early treatment diabetic retinopathy study criteria. The images were graded by fellowship trained retina specialist. DR prevalence included any DR changes in one or both eyes.
Results
Total of 25,196 patients with diabetes were enrolled. Mean age was 54.2 years with Standard Deviation (S.D):12.9 years, ranging from 6 years to 97 years. Type 1 and type 2 diabetes comprised of 451 people (1.79%) and 24,747 (98.21%) respectively. Overall, 1.8% of the images were un-gradable. DR prevalence was 19.3% (95% Confidence Interval (CI): 18.8 − 19.7%). DR prevalence in type 1 and type 2 diabetes was 15.5% (95% CI: 12.5 − 18.6%) and 19.3% (CI: 18.8 − 19.8%) respectively. Clinically significant macular edema (CSME) was found in 5.9% (95% CI: 5.6-6.2%) and VTDR in 7.9% (95% CI: 7.7-8.3%). In multivariate analysis, our study revealed strong evidence to suggest that there is meaningful association between DR and VTDR with duration of diabetes, diabetic foot, diabetic neuropathy, agriculture occupation, those under oral hypoglycaemic agents or insulin or both as compared to those under diet only, and presenting visual acuity > 0.3LogMAR.
Conclusion
Prevalence and associated factors for DR and VTDR were similar to other DR screening programs in the region. Emphasis on wider coverage of DR screening could help for timely detection and treatment of STDR to avoid irreversible blindness.
Publisher
Springer Science and Business Media LLC
Subject
Ophthalmology,General Medicine
Reference42 articles.
1. World Health Organization. Prevention of blindness from Diabetes Mellitus: report of a WHO consultation in Geneva. Geneva: World Health Organization; 2006.
2. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of Diabetes for 2010 and 2030. Diabetes Res ClinPract. 2010;87(1):4–14.
3. Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, et al. Meta-analysis for eye Disease (META-EYE) study group. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35(3):556–64.
4. Early photocoagulation for diabetic retinopathy. ETDRS report 9. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology. 1981;98:766–85.
5. Lane M, Mathewson PA, Shrama HE, Palmer H, Shah P, Nightingale P, et al. Social deprivation as a risk for late presentation of proliferative diabetic retinopathy. Clin Ophthalmol. 2015;9:347–52.